In thyroid cancer cells, miR-200b/c inhibits the activity of the NF-κB/Twist-1 pathway and suppresses cell migration and invasion by reducing RAP1B levels [39]. The gene discussed is RAP1B; the disease is thyroid gland carcinoma.